SciRhom
Developer of therapeutic antibodies designed to improve autoimmune disease therapies. The company creates antibodies against iRhom2, a key modulator of several major pro-inflammatory signaling pathway...
Valuation
$0
Share Price
N/A
Total Raised
$85.6M
Last Round
N/A